Your browser does not support JavaScript!

Santé humaine biotechnologies domaine d'application

505 entreprises et organismes intervenants dans le domaine 'Santé humaine', classés par activité.

Rejoignez la communauté
Trouvez du matériel
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Il y a 3 semaines
Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants was approved today (November...
www.labiotech.eu
MERCK MILLIPORE
est cité dans une actualité de Labiotech.eu
Le 27/09/2022
TILT and MSD working on immunotherapy trial for non-small cell lung cancer
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck...
www.labiotech.eu
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Le 06/09/2022
Sanofi’s Dupixent shows sustained improvement in lung function in children
A maintenance therapy from Sanofi, added to other asthma medications, has shown sustained improvement in lung function, low-rate of asthma attacks and a consistent safety profile for up to two years...
www.labiotech.eu
PFIZER
est cité dans une actualité de Labiotech.eu
Le 29/08/2022
Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”
Moderna is today (August 26) filing patent infringement lawsuits against Pfizer and its partner BioNTech in both the U.S and Germany. The mRNA-focused biotech claims the companies’ Covid-19 vaccine...
www.labiotech.eu
LILLY FRANCE
est cité dans une actualité de Labiotech.eu
Le 30/05/2022
Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two new U.S. sites. The new facilities are located at Indiana’s LEAP Lebanon Innovation and Research District...
www.labiotech.eu
PFIZER
est cité dans une actualité de FierceBiotech
Le 20/05/2022
Pfizer teams up with Headlands Research to launch trial sites in more diverse areas
Pfizer teams up with Headlands Research to launch trial sites in more diverse areas gmasson Thu, 05/19/2022 - 10:38...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Le 12/05/2022
Welcome to New (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal
Welcome to New (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal mbayer Wed, 05/11/2022 - 10:45...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Le 11/05/2022
Starting gun? $11.6B M&A domino falls as Pfizer scoops up Biohaven for phase 3 migraine nasal spray
Starting gun? $11.6B M&A domino falls as Pfizer scoops up Biohaven for phase 3 migraine nasal spray mbayer Tue, 05/10/2022 - 09:25...
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Le 04/05/2022
Another Pfizer gene therapy is free of FDA hold, but delay continues
Another Pfizer gene therapy is free of FDA hold, but delay continues gmasson Tue, 05/03/2022 - 11:00...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 25/04/2022
Chutes & Ladders—Romanelli returns to Merck to lead international human health team after brief CEO stint
Chutes & Ladders—Romanelli returns to Merck to lead international human health team after brief CEO stint mbayer Thu, 04/21/2022 - 17:51...
www.fiercebiotech.com
Charger plus d'actualités